| http://www.w3.org/ns/prov#value | - The Cancer Institute of New Jersey Hematologic Malignancies Program is a university-wide multi-disciplinary group of disease-oriented physicians, scientists, nurses, social workers and other staff members dedicated to optimizing treatments for patients with acute and chronic leukemias, non-Hodgkin's lymphoma, Hodgkin's lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and ot
|
